Molecular Devices is planning to open new offices in China and India and intends to expand its South American operations this year, CEO Joe Keegan told BioCommerce Week.

Keegan also said the company will continue to follow its past strategy of making one small acquisition per year, and cautioned that as Molecular Devices itself matures into an attractive acquisition target, the company would not come cheap.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.